-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KzjEUqo/3BgZnN8ZTPmaj7Qj+uET7ycQRM/8ZxZ6l0z3pnXRhG7q2DvE9uqdL8uM pF3MlNQ1xVsAVz23VWtNJw== 0000000000-09-065499.txt : 20100104 0000000000-09-065499.hdr.sgml : 20100101 20091118165752 ACCESSION NUMBER: 0000000000-09-065499 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091118 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 PUBLIC REFERENCE ACCESSION NUMBER: 0001047469-09-001859 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH\/"](6S4Y-B`Q-3!=+TQI;F5A-IB8&#@86!@6L``!&(<#*B`&8A9 M&#@:&)B0!'F@F(%!B8&']4(21^%D!F89"2UO/H>SO`9:8!E&!@:)%4`:I,\" M(,``_-0'$`T*96YD7!E+U!A M9V4O4&%R96YT(#,@,"!2+U)O=&%T92`P+TUE9&EA0F]X6S`@,"`V,3(@-SDR M72]#7!E+U1R=654>7!E+T9O;G1$97-C!H+8CN_'.??<>WT_X;"H>K=9[SK+!'#( MYCTN@.$7'P,&J92T+R%;]ZZ'50)Y!8S&C`\2=Z==57G18Y#E[N^E1R#(?CEW MLG''8(&_4%(Y@&S4OL8#3GG<'60?SBP898RESG.X7[[TGLDWHV"L\LJL@SZ- MB5EI4,4,GNB$PH,R*PA^9I^\?9>4/Y_4Y09D*AB\"_5,X/]^OI0[O0Y2VB?3 M@!%M@?>O0#`V.&1[`7]\P!]Y)"/K4-K:%!H>RWHY7:FZ?F,A.L9$P]APJ8Q% MMH@JH)Q#O=1P6RH[\[P-ET;/X>ZWSK>UV04Q%43#U_G"<,YALK"D66!*K]2']L`MQ M%&%B5CM,H[&X@H<1('$#]/'>]5Y[R5Y[3F:)DYGW)[OD9! M8,424@:,2G*`%"1XUK`2=3H^I=Z+E8Q+NP;.PL\P+ZTG?FRJ7*W@AU86[HH9 M1ASI7*^GB##B7A+]MPTD)(TB;#<7XR+2L+EU,9M6"&-LEAF,]=1N$84D"I$) M8E]!)(T:/:HN-L?7XI^Q>>1N'6)C+P6A2)%2%PZ53P$S"$4284%/`C05DFTZ@\D#H&ZOCG7]AF-!4X^\&W&3 M`%%S++S!A70SJ0A\O7*W[^->[Q?6+_P^CG"_VEN\-A97S:/)Y+AV+N*ET2[D M29%/^Y+<;RLL[\R:Q5;_.3,=_%(T=S_F>;DM:C=-;JTJ\F4[T9Q5*/A)3D>Z MN,MZ?P48`)K$I=P*#0IE;F1S=')E86T-96YD;V)J#3$U(#`@;V)J/#PO5'EP M92]&;VYT+T5N8V]D:6YG+U=I;D%N MD)6PPV,-6X"P!I`U;&&1'011"$D(`1)"2-@%040%%$5$A*J5,M9M=$9/19TN MKF.M#M9]ZM(#]3#JZ#BT%M>.G1O>=\YCG:Q`J-5H&S*6>=0J,P\6F<5]<9E3@CJ3AWU:F5]3A? MQ=FERJA1X_S<%*M1RFH!0.DFNT$I+\?9#V>Z/B=+@O,"`,ATU3M<^@X;E`T& MTZ4DU;I&O5I5;L#SM.3S+F>0?P+;VT_YU<]"H!X%J_- M^K>VTBT`C*\$P/+F6YO+^P`P\;X=OOC.??BF>2DW&'1AOK[U]?4^:J7&W6*M0&=;464VO_4Q-_9=A/-#_7N+ACKP&OV`>P M+O(`\K<+`.72`%*T#=^!WO0ME9(',O`UW^'>_-S/"?KW4^$^TZ-6K9J+DV3E M8'*COFY^S_19`@*@`B;@`2M@#YR!.Q`"?Q`"PD$TB`?)(!WD@`*P%,A!.=`` M/:@'+:`==($>L!YL`L-@.Q@#N\%^!P_!H_`^^#!\`CX/7X,GX8?P+`(0&L)''!$A(D8D2#I2B)0A>J05Z48& MD5%D/W(,.8M<02:11\@+E(AR40P5HN%H$IJ+RM$:M!7M18?17>AA]#1Z!9U" M9]#7!`;!EN!%""-("8L(*D(]H8LP2-A)^(APAG"-,$UX2B02^40!,8281"P@ M5A";B;W$K<0#Q./$2\2[Q%D2B61%\B)%D-)),I*!U$7:0MI'^HQTF31->DZF MD1W(_N0$8C%H7EQI*P9*Q6U@CK*.L&:Y;- M98O8Z6P-NY>]AWV.?9]#XKAQXCD*3B?G`\XISETNPG7F2KAR[@KN&/<,=YI' MY`EX4EX%KX?W6]X$;\:<8QYHGF?>8#YB_HGY)!_AN_&E_"I^'_\@_SK_I86= M18R%TF*-Q7Z+RQ;/+&TLHRV5EMV6!RRO6;ZTPJSBK2JM-EB-6]VQ1JT]K3.M MZZVW69^Q?F3#LPFWD=MTVQRTN6D+VWK:9MDVVWY@>\%VUL[>+M%.9[?%[I3= M(WN^?;1]A?V`_:?V#QRX#I$.:H"6[[;*;=SMOL!2(!4T"?8*;KLSW*/<:]Q'W:]Z$#W$'I4>6SV^](0] M@SS+/4<\+WK!7L%>:J^M7I>\"=ZAWEKO4>\;0KHP1E@GW"N<\N'[I/IT^(S[ M//9U\2WTW>![UO>U7Y!?E=^8WRT11Y0LZA`=$WWG[^DO]Q_QOQK`"$@(:`LX M$O!MH%>@,G!;X)^#N$%I0:N"3@;](S@D6!^\/_A!B$M(22@A-#:T+?3CT!=AP6&&L(-A?P\7AE>&[PF_OT"P0+E@;,'="*<(6<2.B,E( M++(D\OW(R2C'*%G4:-0WT<[1BNB=T?=B/&(J8O;%/([UB]7'?A3[3!(F628Y M'H?$)<9UQTW$<^)SXX?COTYP2E`E[$V820Q*;$X\GD1(2DG:D'1#:B>52W=+ M9Y)#DIN2S=9$U:SJ69&GZ+?60O5+JD]8N#A M/U,7C.[&E<:INLBZD;KG]7GUAQK8#=J&"XV>C6L:[S4E-/VF&6V6-Y]L<6QI M;YE:%K-L1RO46MIZLLVYK;-M>GGB\EWMU/;*]C]U^'7T=WR_(G_%L4Z[SN6= M=U=VMZ/ZBQZ]GL.>'7GGO%VM% M:X?6_KBN;-U$7W#?MO7$]=KUUS=$;=C5S^YOZK^[,6WCX0%LH'O@^TW%F\X- M!@YNWTS=;-P\.93Z3P"D`5O^F+B9))F0F?R::)K5FT*;KYP M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@ MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R; MO16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFENV<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV M^_>*^!GXJ/DX^7!E+T9O;G1$97-C%LM-38X("TS,#<@,C`P,"`Q,#`W72]&;VYT3F%M92]4:6UE7!E+T9O;G1$97-C M2A4:6UE7!E+U!A9V5S/CX-96YD;V)J#30@ M,"!O8FH\/"],96YG=&@@,S,T.2]4>7!E+TUE=&%D871A+U-U8G1Y<&4O6$U, M/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H M:4AZDY48WIK8SED)S\^"CP_861O8F4M>&%P+69I;'1E#IX;7!M971A('AM;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X M.GAM<'1K/2=835`@=&]O;&MI="`R+CDN,2TQ,RP@9G)A;65W;W)K(#$N-B<^ M#0H\"UN&%P.D-R M96%T;W)4;V]L/2=04V-R:7!T-2YD;&P@5F5R&%P.DUO M9&EF>41A=&4])S(P,#DM,3$M,3A4,38Z,3,Z-#8M,#4Z,#`G('AA<#I#&UL;G,Z>&%P M34T])VAT='`Z+R]N&%P+S$N,"]M;2\G('AA<$U-.D1O M8W5M96YT240])W5U:60Z.#4P-6%F,38M96%D,RTT-V$X+3DR868M-V8T93)B M9F5E-64V)R\^#0H\'!A8VME="!E;F0])W -----END PRIVACY-ENHANCED MESSAGE-----